UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 861177
NEW YORK, NY
Position in XERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,446,043
+$1,571,216 QoQ
Shares Held
687,632
+2.9% QoQ
Ownership
0.377%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 238 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. XERS ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,988 | $282,049,632 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,832,465 | $129,843,910 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
218,164 | $118,207,795 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
504,233 | $84,983,427 | |
| 5 | VTRS |
Viatris Inc
|
4,293,757 | $68,184,856 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
482,743 | $53,555,505 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,510,327 | $37,169,144 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
425,977 | $14,768,619 |
All Filings in XERS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,446,043 | 687,632 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,874,827 | 668,074 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,113,842 | 651,445 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,493,356 | 183,459 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $175,680 | 37,619 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||